Rapid Influenza Detection Tests Evaluated for Viral Antigens
|
By LabMedica International staff writers Posted on 01 Dec 2016 |
|
Image: The rapid influenza detection test Quick Navi-Flu (Photo courtesy of Otsuka Pharmaceutical).
Reverse transcriptase polymerase chain reaction (RT-PCR) has a high sensitivity and a high specificity for the rapid diagnosis of influenza infection; however, the high cost and necessity of specialized equipment have limited the use of RT-PCR in the clinical setting.
Immunochromatography-based rapid influenza virus antigen tests, in which the result appears within 15 minutes, have been used for the early diagnosis of influenza in the clinical setting in Japan. Rapid influenza detection tests (RIDTs) equipped with an instrument-based fluorescence reader system has recently been developed, and their performances have been validated.
Scientists at the Tokyo Medical University (Japan) enrolled a total of 123 participants consisting of 53 men (43.1%) and 70 women (56.9%). The mean age of the patients was 35.1 years (range 20–74 years). The median time to visiting the hospital after illness onset was 26.2 hours (ranging from a few hours to five days). The study was performed from December 2013 to March 2014. Nasopharyngeal swab specimens were collected by performing original swab samplings, which were composed of three swabs.
After collecting the specimens from the participants, the swabs were separated for the tests. One swab was transferred in viral transport medium for virus isolation; the other two swabs were used for the rapid influenza virus antigen detection tests. In this study, the new RIDT GOLD SIGN FLU (Morinaga Milk Industry Co., Ltd, Tokyo, Japan) and Institute of Immunology Co., Ltd, Tokyo, Japan) and the existing immunochromatography-based RIDT Quick Navi-Flu (Otsuka Pharmaceutical Co., Ltd, Tokyo, Japan) were evaluated as compared to viral isolation as the gold standard method.
Among the 123 patients from whom nasopharyngeal swab specimens were collected, 59 tested positive by viral isolation as the gold standard method, 38 with influenza A; 21 with influenza B. For GOLD SIGN FLU, the sensitivities were 73.7% and 81.0%, and the specificities were 97.6% and 98.0% for influenza A and B, respectively. For Quick Navi-Flu, the sensitivities were 86.8% and 85.7%, and the specificities were 98.8% and 100% for influenza A and B, respectively. The time to the appearance of the line on the test strip was less than three minutes for influenza A and less than two minutes for influenza B with both RIDTs in more than 90% of cases.
The authors concluded that GOLD SIGN FLU was useful for diagnosing influenza A, and the result was readily available for influenza B particularly among adult patients. Quick Navi-Flu showed better sensitivities and specificities than GOLD SIGN FLU. The study was published in the November 2016 issue of the International Journal of Infectious Diseases.
Related Links:
Tokyo Medical University
Morinaga Milk Industry
Institute of Immunology
Otsuka Pharmaceutical
Immunochromatography-based rapid influenza virus antigen tests, in which the result appears within 15 minutes, have been used for the early diagnosis of influenza in the clinical setting in Japan. Rapid influenza detection tests (RIDTs) equipped with an instrument-based fluorescence reader system has recently been developed, and their performances have been validated.
Scientists at the Tokyo Medical University (Japan) enrolled a total of 123 participants consisting of 53 men (43.1%) and 70 women (56.9%). The mean age of the patients was 35.1 years (range 20–74 years). The median time to visiting the hospital after illness onset was 26.2 hours (ranging from a few hours to five days). The study was performed from December 2013 to March 2014. Nasopharyngeal swab specimens were collected by performing original swab samplings, which were composed of three swabs.
After collecting the specimens from the participants, the swabs were separated for the tests. One swab was transferred in viral transport medium for virus isolation; the other two swabs were used for the rapid influenza virus antigen detection tests. In this study, the new RIDT GOLD SIGN FLU (Morinaga Milk Industry Co., Ltd, Tokyo, Japan) and Institute of Immunology Co., Ltd, Tokyo, Japan) and the existing immunochromatography-based RIDT Quick Navi-Flu (Otsuka Pharmaceutical Co., Ltd, Tokyo, Japan) were evaluated as compared to viral isolation as the gold standard method.
Among the 123 patients from whom nasopharyngeal swab specimens were collected, 59 tested positive by viral isolation as the gold standard method, 38 with influenza A; 21 with influenza B. For GOLD SIGN FLU, the sensitivities were 73.7% and 81.0%, and the specificities were 97.6% and 98.0% for influenza A and B, respectively. For Quick Navi-Flu, the sensitivities were 86.8% and 85.7%, and the specificities were 98.8% and 100% for influenza A and B, respectively. The time to the appearance of the line on the test strip was less than three minutes for influenza A and less than two minutes for influenza B with both RIDTs in more than 90% of cases.
The authors concluded that GOLD SIGN FLU was useful for diagnosing influenza A, and the result was readily available for influenza B particularly among adult patients. Quick Navi-Flu showed better sensitivities and specificities than GOLD SIGN FLU. The study was published in the November 2016 issue of the International Journal of Infectious Diseases.
Related Links:
Tokyo Medical University
Morinaga Milk Industry
Institute of Immunology
Otsuka Pharmaceutical
New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
New
Auto Clinical Chemistry Analyzer
cobas c 703
New
Multi-Function Pipetting Platform
apricot PP5
Latest Microbiology News
- Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
- Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
Molecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Pathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read more
Technology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Industry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
